Here's Why Trump's Ukraine Strategy Is Better Than Biden's
JD Vance Didn't Hold Back on Bolton, Ukraine, and Crime in This Interview
Armed and Deployed: Trump’s National Guard Crackdown in D.C. Sends Clear Warning to...
Nine Days, Zero Murders: Trump’s D.C. Crackdown Delivers Results
Arizona Charges 170 in Immigration Sweep
CNN Admits the Brutal Truth: Democrats Are Bleeding Voters
Trump Will Send Troops to Baltimore if It Needs Help
Chinese Scammer Sentenced to 24 Months in Prison
DeSantis Defends Removal of Rainbow LGBT Crosswalk
Boston Cops Defy Left-Wing Mayor Michelle Wu, Secretly Aid ICE in Arresting Criminal...
Vivek Ramaswamy Surges Ahead in Ohio Governor's Race
FBI's 'Summer Heat' Initiative Under Trump to Make the U.S. Safe Again
California’s Homeless Crisis: Two Decades of Empty Promises Under Newsom’s Watch
When Envy Becomes a Political Weapon
Socialist Zohran Mamdani’s Muscle Showdown Falls Flat as Social Media Roasts His Bench...
Tipsheet

RFK Jr.: European Price-Fixing Led to Trump Pharmaceutical EO

AP Photo/Mark Schiefelbein

Health and Human Services Secretary Robert F. Kennedy Jr. said Monday that the catalyst behind President Trump’s executive order to reduce prescription drug costs for Americans was the European nations’ price-fixing.

Advertisement

Even though Americans are only 4.2 percent of the world's population, they account for 75 percent of pharmaceutical company revenue, which ends up with Americans paying more for prescription drugs than everyone else.

“It's not really the pharmaceutical industry's fault. It's the European nations who are price-fixing, and taking advantage of us, and so we are now going to fix that,” Kennedy told Newsmax.

Trump’s executive order says that U.S. Trade Representative Jamieson Greer and the Commerce Department should ensure that other countries pay their fair share in research and development for pharmaceuticals. It also calls for using a Most Favored Nation policy, which sets drug prices based on their prices in foreign nations, to lower prescription drug prices here. In 2020, a federal judge blocked this program’s implementation.

In addition, the EO would enable Kennedy to “establish a mechanism through which American patients can buy their drugs directly from manufacturers who sell to Americans at a Most Favored Nation price, bypassing middlemen.”

Advertisement

Kennedy believes that the EO will stick, and talked to many pharmaceutical company CEOs last week to tell them what may be coming.

“The pharmaceutical companies know that it's time, and we've been meeting with them, and you know this was not a surprise to them. I had meetings with most of the CEOs last week, and I gave them at least a veiled warning that this was coming, but they knew it was coming. We have ways of enforcing this if we can't come to an agreement,” Kennedy said.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement